DexCom Inc (XTER:DC4)
€ 78.11 5.59 (7.71%) Market Cap: 29.79 Bil Enterprise Value: 29.88 Bil PE Ratio: 47.63 PB Ratio: 15.70 GF Score: 73/100

DexCom Inc Investor Day Transcript

Dec 09, 2020 / 04:30PM GMT
Release Date Price: €2.91
Operator

Please welcome Director of Corporate Affairs and Head of Investor Relations, Sean Christensen.

Sean Christensen
DexCom, Inc. - Senior IR Manager

Good morning, everyone, and welcome to DexCom's 2020 Investor Day. We're glad that you could join us today, even though we would much rather see you face to face. We look forward to being able to do that again, hopefully soon and hope that you and your families are safe and well as we head toward the end of this year.

In the meantime, we're excited to present today and have a great lineup of speakers ahead. This includes several of the key leaders of the DexCom management team as we provide detail on DexCom's growth opportunity and an update to the company's long-term financial goals. We're also going to take advantage of the virtual format today to let you hear directly from clinicians who are using DexCom CGM in innovative ways in their practices. These are some of the true leaders in their fields, and we think their firsthand experience will provide you with a valuable perspective as we think of the impact

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot